Pavel Khrimian Email

Co-founder & CBO . Deka BioSciences

Current Roles

Employees:
52
Revenue:
$8.1M
About
Deka Biosciences, Inc., is an early-stage biotechnology company focused on generating the next generation targeted cytokine therapies to treat cancer and inflammatory diseases. Deka is developing the dual cytokine, (DiakineTM) platform. Diakines are comprised of optimized, stimulatory, or suppressive disease specific IL-10 variants coupled to other stimulatory or suppressive cytokines via a T1/2 life extending tissue targeting, non-immunogenic scFv technology.
Deka BioSciences Address
20378 Seneca Meadows Pkwy
Rockville, null
Deka BioSciences Email

Past Companies

Deka Biosciences, IncCo-founder & CBO
ReliableSource Consulting, LLCPresident
MedImmuneAssociate Director, Partnering and Strategy

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.